- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The drugmaker's shares were hammered Friday on news that the industry is slashing prices.
Posting results 'not as a bad as we thought' has become a successful strategy. It worked for Bristol.
JPMorgan expects Valeant (VRX) to cut its 2016 full-year earnings guidance and said it is 'cautious' on the stock.